{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T21:57:38Z","timestamp":1792447058081,"version":"4.5.0"},"reference-count":31,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["mp.uscap.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Modern Pathology"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.modpat.2026.101005","type":"journal-article","created":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T23:36:40Z","timestamp":1776814600000},"page":"101005","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Copy Number-low\/TP53-mutated Endometrial Cancer With Wild-type p53 Immunoexpression: Implications for Risk Stratification and Management When Using Next-generation Sequencing for Molecular Classification"],"prefix":"10.1016","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1120-5015","authenticated-orcid":false,"given":"Joseph T.","family":"Rabban","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca J.","family":"Wolsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neslihan","family":"Kayraklioglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kurtis D.","family":"Davies","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dara L.","family":"Aisner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W. Patrick","family":"Devine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7447","key":"10.1016\/j.modpat.2026.101005_bib1","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/nature12113","article-title":"Integrated genomic characterization of endometrial carcinoma","volume":"497","author":"Kandoth","year":"2013","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.modpat.2026.101005_bib2","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1136\/ijgc-2020-002230","article-title":"ESGO\/ESTRO\/ESP guidelines for the management of patients with endometrial carcinoma","volume":"31","author":"Concin","year":"2021","journal-title":"Int J Gynecol Cancer"},{"issue":"1","key":"10.1016\/j.modpat.2026.101005_bib3","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.ygyno.2021.10.071","article-title":"Cost-effectiveness analysis of tumor molecular classification in high-risk early-stage endometrial cancer","volume":"164","author":"Orellana","year":"2022","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.modpat.2026.101005_bib4","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.ygyno.2023.04.010","article-title":"Cost-effectiveness analysis of tumor molecular testing in stage III endometrial cancer","volume":"173","author":"Orellana","year":"2023","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.modpat.2026.101005_bib5","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.ygyno.2023.09.006","article-title":"Budget impact analysis of molecular subtype profiling in endometrial cancer","volume":"178","author":"Plotkin","year":"2023","journal-title":"Gynecol Oncol"},{"issue":"1","key":"10.1016\/j.modpat.2026.101005_bib6","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1186\/s12905-023-02677-6","article-title":"Molecular-based classification of endometrial carcinoma in Northern Thailand: impact on prognosis and potential for implementation in resource-limited settings","volume":"23","author":"Dankai","year":"2023","journal-title":"BMC Womens Health"},{"key":"10.1016\/j.modpat.2026.101005_bib7","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1038\/s41379-021-00963-y","article-title":"Prospective molecular classification of endometrial carcinomas: institutional implementation, practice, and clinical experience","volume":"35","author":"Devereaux","year":"2022","journal-title":"Mod Pathol"},{"issue":"5","key":"10.1016\/j.modpat.2026.101005_bib8","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1002\/cncr.30496","article-title":"Confirmation of ProMisE: a simple, genomics-based clinical classifier for endometrial cancer","volume":"123","author":"Talhouk","year":"2017","journal-title":"Cancer"},{"issue":"4","key":"10.1016\/j.modpat.2026.101005_bib9","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1097\/PGP.0000000000000898","article-title":"Targeted molecular testing in endometrial carcinoma: validation of a clinically driven selective ProMisE testing protocol","volume":"42","author":"Talhouk","year":"2023","journal-title":"Int J Gynecol Pathol"},{"issue":"1","key":"10.1016\/j.modpat.2026.101005_bib10","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.ygyno.2020.01.019","article-title":"Analysis of 108 patients with endometrial carcinoma using the PROMISE classification and additional genetic analyses for MMR-D","volume":"157","author":"Timmerman","year":"2020","journal-title":"Gynecol Oncol"},{"issue":"3","key":"10.1016\/j.modpat.2026.101005_bib11","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1002\/path.5373","article-title":"Clinicopathological and molecular characterisation of 'multiple-classifier' endometrial carcinomas","volume":"250","author":"Leon-Castillo","year":"2020","journal-title":"J Pathol"},{"issue":"1","key":"10.1016\/j.modpat.2026.101005_bib12","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1136\/ijgc-2022-004039","article-title":"Refining adjuvant treatment in endometrial cancer based on molecular features: the RAINBO clinical trial program","volume":"33","year":"2023","journal-title":"Int J Gynecol Cancer"},{"issue":"27","key":"10.1016\/j.modpat.2026.101005_bib13","doi-asserted-by":"crossref","first-page":"4369","DOI":"10.1200\/JCO.23.00062","article-title":"Molecular classification predicts response to radiotherapy in the randomized PORTEC-1 and PORTEC-2 trials for early-stage endometrioid endometrial cancer","volume":"41","author":"Horeweg","year":"2023","journal-title":"J Clin Oncol"},{"issue":"4","key":"10.1016\/j.modpat.2026.101005_bib14","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1136\/ijgc-2023-005149","article-title":"Recurrence rates and patterns of recurrence in stage IA p53abn endometrial cancer with and without myometrial invasion","volume":"34","author":"Jamieson","year":"2024","journal-title":"Int J Gynecol Cancer"},{"issue":"1","key":"10.1016\/j.modpat.2026.101005_bib15","doi-asserted-by":"crossref","first-page":"3388","DOI":"10.1200\/JCO.20.00549","article-title":"Molecular classification of the PORTEC-3 trial for high-risk endometrial cancer: impact on prognosis and benefit from adjuvant therapy","volume":"38","author":"Leon-Castillo","year":"2020","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.modpat.2026.101005_bib16","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S1470-2045(25)00612-6","article-title":"Molecular profile-based adjuvant treatment for women with high-intermediate risk endometrial cancer (PORTEC-4a): results of a randomised, open-label, phase 3, multicentre, non-inferiority trial","volume":"27","author":"van den Heerik","year":"2026","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.modpat.2026.101005_bib17","series-title":"Classification of Female Genital Tumors","year":"2020"},{"issue":"2","key":"10.1016\/j.modpat.2026.101005_bib18","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.ijgo.2009.02.012","article-title":"Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium","volume":"105","author":"Pecorelli","year":"2009","journal-title":"Int J Gynaecol Obstet"},{"issue":"2","key":"10.1016\/j.modpat.2026.101005_bib19","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1002\/ijgo.14923","article-title":"FIGO staging of endometrial cancer: 2023","volume":"162","author":"Berek","year":"2023","journal-title":"Int J Gynaecol Obstet"},{"issue":"Suppl 1","key":"10.1016\/j.modpat.2026.101005_bib20","doi-asserted-by":"crossref","first-page":"S123","DOI":"10.1097\/PGP.0000000000000488","article-title":"Interpretation of p53 immunohistochemistry in endometrial carcinomas: toward increased reproducibility","volume":"38","author":"Kobel","year":"2019","journal-title":"Int J Gynecol Pathol"},{"issue":"3","key":"10.1016\/j.modpat.2026.101005_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.acpath.2023.100090","article-title":"The Genomics Organization for Academic Laboratories (GOAL): a vision for a genomics future for academic pathology","volume":"10","author":"Aisner","year":"2023","journal-title":"Acad Pathol"},{"issue":"4","key":"10.1016\/j.modpat.2026.101005_bib23","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1097\/PGP.0000000000000994","article-title":"Prospective clinical prognostication of endometrial carcinomas based on next-generation sequencing and immunohistochemistry-real-world implementation and results at a tertiary care center","volume":"43","author":"Davies","year":"2024","journal-title":"Int J Gynecol Pathol"},{"issue":"1","key":"10.1016\/j.modpat.2026.101005_bib24","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1097\/PGP.0000000000000710","article-title":"MSI testing in endometrial cancer: proceedings of the ISGyP companion society session at the USCAP 2020 annual meeting","volume":"40","author":"Casey","year":"2021","journal-title":"Int J Gynecol Pathol"},{"issue":"4","key":"10.1016\/j.modpat.2026.101005_bib25","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1111\/his.15365","article-title":"Initiation of molecular testing of endometrial carcinomas in a population-based setting: practical considerations and pitfalls","volume":"86","author":"Machuca-Aguado","year":"2025","journal-title":"Histopathology"},{"issue":"9","key":"10.1016\/j.modpat.2026.101005_bib26","doi-asserted-by":"crossref","first-page":"2613","DOI":"10.1158\/1078-0432.CCR-20-4436","article-title":"Clinicopathologic and genomic analysis of TP53-mutated endometrial carcinomas","volume":"27","author":"Momeni-Boroujeni","year":"2021","journal-title":"Clin Cancer Res"},{"issue":"3","key":"10.1016\/j.modpat.2026.101005_bib27","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1002\/path.5375","article-title":"p53 immunohistochemistry is an accurate surrogate for TP53 mutational analysis in endometrial carcinoma biopsies","volume":"250","author":"Singh","year":"2020","journal-title":"J Pathol"},{"issue":"2","key":"10.1016\/j.modpat.2026.101005_bib28","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/bjc.2015.190","article-title":"A clinically applicable molecular-based classification for endometrial cancers","volume":"113","author":"Talhouk","year":"2015","journal-title":"Br J Cancer"},{"issue":"10","key":"10.1016\/j.modpat.2026.101005_bib29","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1038\/s41379-022-01102-x","article-title":"p53 immunohistochemistry in endometrial cancer: clinical and molecular correlates in the PORTEC-3 trial","volume":"35","author":"Vermij","year":"2022","journal-title":"Mod Pathol"},{"issue":"2","key":"10.1016\/j.modpat.2026.101005_bib30","doi-asserted-by":"crossref","first-page":"e71","DOI":"10.1016\/S2589-7500(22)00210-2","article-title":"Interpretable deep learning model to predict the molecular classification of endometrial cancer from haematoxylin and eosin-stained whole-slide images: a combined analysis of the PORTEC randomised trials and clinical cohorts","volume":"5","author":"Fremond","year":"2023","journal-title":"Lancet Digit Health"},{"key":"10.1016\/j.modpat.2026.101005_bib31","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.cancergen.2019.10.005","article-title":"High-resolution copy number analysis of clear cell endometrial carcinoma","volume":"240","author":"O\u2019Hara","year":"2020","journal-title":"Cancer Genet"},{"issue":"7","key":"10.1016\/j.modpat.2026.101005_bib32","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1136\/ijgc-2024-005295","article-title":"Copy number variations in endometrial cancer: from biological significance to clinical utility","volume":"34","author":"Dugo","year":"2024","journal-title":"Int J Gynecol Cancer"}],"container-title":["Modern Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395226000487?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395226000487?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T11:31:51Z","timestamp":1781695911000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0893395226000487"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":31,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["S0893395226000487"],"URL":"https:\/\/doi.org\/10.1016\/j.modpat.2026.101005","relation":{},"ISSN":["0893-3952"],"issn-type":[{"value":"0893-3952","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Copy Number-low\/TP53-mutated Endometrial Cancer With Wild-type p53 Immunoexpression: Implications for Risk Stratification and Management When Using Next-generation Sequencing for Molecular Classification","name":"articletitle","label":"Article Title"},{"value":"Modern Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.modpat.2026.101005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 United States & Canadian Academy of Pathology. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"101005"}}